GlassScriptPhysician profile
Antonia P Ahern
NPI 1295053742
$7,601.41
in general payments reported to CMS, 2019-2025
65 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,539 · 2020: $276 · 2021: $580 · 2022: $901 · 2023: $1,223 · 2024: $1,868 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,194 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,193.89 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $944.44 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Allergan, INC. | $506.54 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $490.38 | 2019-2025 | Ajovy |
| Biogen, INC. | $457.78 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Ucb, INC. | $436.14 | 2019-2025 | Rystiggo, Briviact, Fintepla |
| Novartis Pharmaceuticals Corporation | $421.34 | 2019-2025 | |
| Pfizer INC. | $373.87 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $280.36 | 2019-2025 | Ultomiris |
| Emd Serono, INC. | $268.75 | 2019-2025 | Mavenclad |
| E.R. Squibb & Sons, L.L.C. | $227.88 | 2021-2024 | Zeposia |
| Jazz Pharmaceuticals INC. | $197.05 | 2020-2025 | |
| Lilly USA, LLC | $170.86 | 2019-2025 | Reyvow, Emgality, Kisunla |
| Eisai INC. | $142.76 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $140.65 | 2021-2025 | Wainua |
| Neurocrine Biosciences, INC. | $128.81 | 2021-2025 | Ingrezza, Ongentys |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonia Ahern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.